<p>随着全球市场经历主要指数创下新高和经济指标波动的混合状态，投资者密切关注小型股的表现，例如在罗素 2000 指数中的股票，这些股票在更广泛的市场波动中显示出积极的走势。在这个动态环境中，识别未被发现的潜力股——那些由于坚实的基本面和战略定位而具有增长潜力的股票——可以有效增强投资组合的韧性和多样性。</p>
<h3>全球十大未被发现的基本面强劲的潜力股</h3>
<table>
<thead>
<tr>
<th>名称</th>
<th>负债权益比</th>
<th>收入增长</th>
<th>盈利增长</th>
<th>健康评级</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brillian Network \u0026 Automation Integrated System</td>
<td>NA</td>
<td>22.16%</td>
<td>22.91%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Saha-Union</td>
<td>0.84%</td>
<td>0.90%</td>
<td>15.45%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>ManpowerGroup Greater China</td>
<td>NA</td>
<td>15.01%</td>
<td>0.09%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>National General Insurance (P.J.S.C.)</td>
<td>NA</td>
<td>14.55%</td>
<td>29.05%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>TSTE</td>
<td>36.22%</td>
<td>3.96%</td>
<td>-8.49%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Practic</td>
<td>5.21%</td>
<td>4.49%</td>
<td>7.23%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>Mechema Chemicals International</td>
<td>55.74%</td>
<td>-4.23%</td>
<td>-5.72%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>Fengyinhe Holdings</td>
<td>0.60%</td>
<td>39.37%</td>
<td>65.41%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>National Corporation for Tourism and Hotels</td>
<td>19.25%</td>
<td>0.67%</td>
<td>4.89%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>Saudi Chemical Holding</td>
<td>79.49%</td>
<td>16.57%</td>
<td>44.01%</td>
<td>★★★★☆☆</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们全球未被发现的基本面强劲的潜力股筛选器中的 3163 只股票的完整列表。</p>
<p>让我们探索筛选结果中的几个突出选项。</p>
<h2>东北制药集团 (SZSE:000597)</h2>
<p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> 东北制药集团有限公司在中国从事化学制药制剂、制药业务、制药工程和生物医学领域的运营，市值为 86.6 亿人民币。</p>
<p><strong>运营：</strong> 东北制药集团主要通过其化学制药制剂和制药业务部门产生收入。该公司的净利润率经历了波动，反映出运营效率和成本管理的变化。</p>
<p>东北制药集团在过去一年中显示出良好的增长迹象，盈利增长率为 12.3%，超过行业平均水平的-2.5%。公司的负债权益比在五年内显著降低，从 94% 降至 37.5%，表明财务状况更强。其市盈率为 23.2 倍，低于中国市场平均水平的 41.8 倍，暗示其相对于同行可能被低估。尽管 2025 年第一季度净收入从去年的 5800 万人民币降至 3600 万人民币，但它仍然产生正的自由现金流，并保持高质量的盈利。</p>
<ul>
<li>点击探索我们在东北制药集团健康报告中的详细发现。</li>
<li>了解东北制药集团的历史表现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/256e9d33-79b2-46c8-b8c0-059939fce028/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/256e9d33-79b2-46c8-b8c0-059939fce028/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:000597 截至 2025 年 7 月的盈利和收入增长</p>
<h2>筑博设计 (SZSE:300564)</h2>
<p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> 筑博设计有限公司在中国提供建筑设计和咨询服务，市值为 33.7 亿人民币。</p>
<p><strong>运营：</strong> 该公司主要通过建筑设计和咨询服务产生收入，市值为 33.7 亿人民币，专注于提供专业设计解决方案。</p>
<p>筑博设计作为专业服务行业中的小型参与者，展现出引人注目的财务动态。去年盈利增长 28%，超过行业平均水平的-0.5%，尽管五年内年均下降 19.8%。该公司保持无债务状态，减轻了对利息支付的担忧，使其能够专注于运营增长。最近报告的第一季度销售额为 5794 万人民币，净亏损从去年的 5350 万人民币减少至 2768 万人民币，表明在股价波动和一次性收益 5870 万人民币影响近期业绩的情况下，运营有所改善。</p>
<ul>
<li>点击这里发现筑博设计的细微差别，查看我们的详细分析健康报告。</li>
<li>查看我们的历史表现报告，以获取对筑博设计过去表现的洞察。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ebf3a1e9-89b4-4359-9481-7b2346cb4bf4/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ebf3a1e9-89b4-4359-9481-7b2346cb4bf4/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:300564 截至 2025 年 7 月的盈利和收入增长</p>
<h2>山东大学电力技术 (SZSE:301609)</h2>
<p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> 山东大学电力技术有限公司从事电力技术解决方案的开发和提供，市值为 23.9 亿人民币。</p>
<p><strong>运营：</strong> 山东大学电力技术主要通过其电力技术解决方案产生收入。该公司的市值为 23.9 亿人民币，表明其在行业中的规模。</p>
<p>山东大学电力技术作为电气行业中的灵活参与者，在过去一年中展现出 19.4% 的显著盈利增长，超过行业平均水平的-1.2%。该公司无债务交易，且交易价格低于其估计的公允价值 21.1%，表明市场可能低估。最近完成了一笔价值 5.37 亿人民币的首次公开募股，股票定价为 14.66 人民币，尽管其流动性较低且缺乏近期财务数据更新，但似乎有进一步扩展的潜力。该公司报告了高质量的盈利，在当前挑战中呈现出引人注目的机会。</p>
<ul>
<li>通过我们的综合健康报告，深入了解山东大学电力技术的复杂性。</li>
<li>通过查看我们的历史业绩报告，获取山东大学电力技术的历史表现洞察。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/6f87b60c-2f2a-4e58-aece-5e623eddf3dc/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/6f87b60c-2f2a-4e58-aece-5e623eddf3dc/chart/debt-equity-history-analysis"/></p>
<p>SZSE:301609 截至 2025 年 7 月的债务与股本比率</p>
<h2>让它发生</h2>
<ul>
<li>点击这里，仔细查看我们全球未被发现的强基本面公司名单，共 3163 家公司。</li>
<li>投资了这些股票吗？通过 Simply Wall St 简化您的投资组合管理，并通过我们的警报及时了解您股票的任何重要更新。</li>
<li>使用 Simply Wall St 应用程序提升您的投资能力，享受覆盖每个大洲的基本市场情报的免费访问。</li>
</ul>
<h2>寻找替代机会？</h2>
<ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>用显示强劲增长潜力的公司充实您的投资组合，这些公司得到了分析师和管理层的乐观展望支持。</li>
<li>寻找现金流潜力良好但交易价格低于其公允价值的公司。</li>
</ul>
<p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>

筑博设计

<p>随着全球市场波动，投资者正关注像罗素 2000 指数中的小型股。识别具有强大基本面的未被发现的潜力股可以增强投资组合的韧性。值得注意的公司包括东北制药集团、筑博设计和山东大学电力科技，这些公司都显示出良好的盈利增长和潜在的低估。这些公司在各自的行业中位置良好，使其成为在市场波动中寻求增长机会的投资者的吸引选项</p>

<p>As global markets experience a mix of record highs in major indices and fluctuating economic indicators, investors are keenly observing the performance of small-cap stocks like those in the Russell 2000, which have shown positive movement amidst broader market volatility. In this dynamic environment, identifying undiscovered gems—stocks that offer potential for growth due to solid fundamentals and strategic positioning—can be an effective way to enhance your portfolio's resilience and diversity.</p>
<div class="lb-trans"><p>随着全球市场经历主要指数创下新高和经济指标波动的混合状态，投资者密切关注小型股的表现，例如在罗素 2000 指数中的股票，这些股票在更广泛的市场波动中显示出积极的走势。在这个动态环境中，识别未被发现的潜力股——那些由于坚实的基本面和战略定位而具有增长潜力的股票——可以有效增强投资组合的韧性和多样性。</p>
</div><h3>Top 10 Undiscovered Gems With Strong Fundamentals Globally</h3>
<div class="lb-trans"><h3>全球十大未被发现的基本面强劲的潜力股</h3>
</div><table>
<thead>
<tr>
<th>Name</th>
<th>Debt To Equity</th>
<th>Revenue Growth</th>
<th>Earnings Growth</th>
<th>Health Rating</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brillian Network &amp; Automation Integrated System</td>
<td>NA</td>
<td>22.16%</td>
<td>22.91%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Saha-Union</td>
<td>0.84%</td>
<td>0.90%</td>
<td>15.45%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>ManpowerGroup Greater China</td>
<td>NA</td>
<td>15.01%</td>
<td>0.09%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>National General Insurance (P.J.S.C.)</td>
<td>NA</td>
<td>14.55%</td>
<td>29.05%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>TSTE</td>
<td>36.22%</td>
<td>3.96%</td>
<td>-8.49%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Practic</td>
<td>5.21%</td>
<td>4.49%</td>
<td>7.23%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>Mechema Chemicals International</td>
<td>55.74%</td>
<td>-4.23%</td>
<td>-5.72%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>Fengyinhe Holdings</td>
<td>0.60%</td>
<td>39.37%</td>
<td>65.41%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>National Corporation for Tourism and Hotels</td>
<td>19.25%</td>
<td>0.67%</td>
<td>4.89%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>Saudi Chemical Holding</td>
<td>79.49%</td>
<td>16.57%</td>
<td>44.01%</td>
<td>★★★★☆☆</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>名称</th>
<th>负债权益比</th>
<th>收入增长</th>
<th>盈利增长</th>
<th>健康评级</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brillian Network \u0026 Automation Integrated System</td>
<td>NA</td>
<td>22.16%</td>
<td>22.91%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Saha-Union</td>
<td>0.84%</td>
<td>0.90%</td>
<td>15.45%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>ManpowerGroup Greater China</td>
<td>NA</td>
<td>15.01%</td>
<td>0.09%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>National General Insurance (P.J.S.C.)</td>
<td>NA</td>
<td>14.55%</td>
<td>29.05%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>TSTE</td>
<td>36.22%</td>
<td>3.96%</td>
<td>-8.49%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Practic</td>
<td>5.21%</td>
<td>4.49%</td>
<td>7.23%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>Mechema Chemicals International</td>
<td>55.74%</td>
<td>-4.23%</td>
<td>-5.72%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>Fengyinhe Holdings</td>
<td>0.60%</td>
<td>39.37%</td>
<td>65.41%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>National Corporation for Tourism and Hotels</td>
<td>19.25%</td>
<td>0.67%</td>
<td>4.89%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>Saudi Chemical Holding</td>
<td>79.49%</td>
<td>16.57%</td>
<td>44.01%</td>
<td>★★★★☆☆</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 3163 stocks from our Global Undiscovered Gems With Strong Fundamentals screener.</p>
<div class="lb-trans"><p>点击这里查看我们全球未被发现的基本面强劲的潜力股筛选器中的 3163 只股票的完整列表。</p>
</div><p>Let's explore several standout options from the results in the screener.</p>
<div class="lb-trans"><p>让我们探索筛选结果中的几个突出选项。</p>
</div><h2>Northeast Pharmaceutical Group (SZSE:000597)</h2>
<div class="lb-trans"><h2>东北制药集团 (SZSE:000597)</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Northeast Pharmaceutical Group Co., Ltd. operates in the fields of chemical pharmaceuticals preparations, pharmaceutical business, pharmaceutical engineering, and biomedicine in China with a market cap of CN¥8.66 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 东北制药集团有限公司在中国从事化学制药制剂、制药业务、制药工程和生物医学领域的运营，市值为 86.6 亿人民币。</p>
</div><p><strong>Operations:</strong> Northeast Pharmaceutical Group generates revenue primarily from its chemical pharmaceuticals preparations and pharmaceutical business segments. The company has observed fluctuations in its net profit margin, reflecting changes in operational efficiency and cost management.</p>
<div class="lb-trans"><p><strong>运营：</strong> 东北制药集团主要通过其化学制药制剂和制药业务部门产生收入。该公司的净利润率经历了波动，反映出运营效率和成本管理的变化。</p>
</div><p>Northeast Pharmaceutical Group is showing promising signs with its earnings growth of 12.3% over the past year, outpacing the industry average of -2.5%. The company's debt to equity ratio has impressively reduced from 94% to 37.5% in five years, indicating a stronger financial position. Its price-to-earnings ratio stands at 23.2x, which is below the CN market average of 41.8x, suggesting it could be undervalued relative to peers. Despite a drop in net income for Q1 2025 to CNY 36 million from CNY 58 million last year, it continues to generate positive free cash flow and maintain high-quality earnings.</p>
<div class="lb-trans"><p>东北制药集团在过去一年中显示出良好的增长迹象，盈利增长率为 12.3%，超过行业平均水平的-2.5%。公司的负债权益比在五年内显著降低，从 94% 降至 37.5%，表明财务状况更强。其市盈率为 23.2 倍，低于中国市场平均水平的 41.8 倍，暗示其相对于同行可能被低估。尽管 2025 年第一季度净收入从去年的 5800 万人民币降至 3600 万人民币，但它仍然产生正的自由现金流，并保持高质量的盈利。</p>
</div><ul>
<li>Click to explore a detailed breakdown of our findings in Northeast Pharmaceutical Group's health report.</li>
<li>Learn about Northeast Pharmaceutical Group's historical performance.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击探索我们在东北制药集团健康报告中的详细发现。</li>
<li>了解东北制药集团的历史表现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/256e9d33-79b2-46c8-b8c0-059939fce028/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/256e9d33-79b2-46c8-b8c0-059939fce028/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:000597 Earnings and Revenue Growth as at Jul 2025</p>
<div class="lb-trans"><p>SZSE:000597 截至 2025 年 7 月的盈利和收入增长</p>
</div><h2>Zhubo Design (SZSE:300564)</h2>
<div class="lb-trans"><h2>筑博设计 (SZSE:300564)</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Zhubo Design Co., Ltd provides architectural design and consulting services in China, with a market cap of CN¥3.37 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 筑博设计有限公司在中国提供建筑设计和咨询服务，市值为 33.7 亿人民币。</p>
</div><p><strong>Operations:</strong> The company generates revenue primarily from architectural design and consulting services in China. With a market cap of CN¥3.37 billion, it focuses on providing specialized design solutions.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司主要通过建筑设计和咨询服务产生收入，市值为 33.7 亿人民币，专注于提供专业设计解决方案。</p>
</div><p>Zhubo Design, a smaller player in the professional services sector, has shown intriguing financial dynamics. Earnings surged 28% last year, outpacing the industry average of -0.5%, despite a 19.8% annual decrease over five years. The company remains debt-free, alleviating concerns about interest payments and allowing focus on operational growth. Recently reported sales for Q1 were CN¥57.94 million, with a net loss reduced to CN¥27.68 million from CN¥53.5 million the previous year, indicating some operational improvement amidst volatility in share price and one-off gains of CN¥58.7 million affecting recent results.</p>
<div class="lb-trans"><p>筑博设计作为专业服务行业中的小型参与者，展现出引人注目的财务动态。去年盈利增长 28%，超过行业平均水平的-0.5%，尽管五年内年均下降 19.8%。该公司保持无债务状态，减轻了对利息支付的担忧，使其能够专注于运营增长。最近报告的第一季度销售额为 5794 万人民币，净亏损从去年的 5350 万人民币减少至 2768 万人民币，表明在股价波动和一次性收益 5870 万人民币影响近期业绩的情况下，运营有所改善。</p>
</div><ul>
<li>Click here to discover the nuances of Zhubo Design with our detailed analytical health report.</li>
<li>Review our historical performance report to gain insights into Zhubo Design's's past performance.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里发现筑博设计的细微差别，查看我们的详细分析健康报告。</li>
<li>查看我们的历史表现报告，以获取对筑博设计过去表现的洞察。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ebf3a1e9-89b4-4359-9481-7b2346cb4bf4/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/ebf3a1e9-89b4-4359-9481-7b2346cb4bf4/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:300564 Earnings and Revenue Growth as at Jul 2025</p>
<div class="lb-trans"><p>SZSE:300564 截至 2025 年 7 月的盈利和收入增长</p>
</div><h2>Shandong University Electric Power Technology (SZSE:301609)</h2>
<div class="lb-trans"><h2>山东大学电力技术 (SZSE:301609)</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Shandong University Electric Power Technology Co., Ltd. is engaged in the development and provision of electric power technology solutions, with a market cap of CN¥2.39 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 山东大学电力技术有限公司从事电力技术解决方案的开发和提供，市值为 23.9 亿人民币。</p>
</div><p><strong>Operations:</strong> Shandong University Electric Power Technology generates revenue primarily through its electric power technology solutions. The company has a market capitalization of CN¥2.39 billion, indicating its scale within the industry.</p>
<div class="lb-trans"><p><strong>运营：</strong> 山东大学电力技术主要通过其电力技术解决方案产生收入。该公司的市值为 23.9 亿人民币，表明其在行业中的规模。</p>
</div><p>Shandong University Electric Power Technology, a nimble player in the electrical industry, has demonstrated impressive earnings growth of 19.4% over the past year, outpacing the industry average of -1.2%. This company stands debt-free and trades at 21.1% below its estimated fair value, indicating potential undervaluation in the market. Recently completing an IPO worth CNY 537 million with shares priced at CNY 14.66 each, it seems poised for further expansion despite its highly illiquid shares and lack of recent financial data updates. With high-quality earnings reported, this firm presents an intriguing opportunity amidst its current challenges.</p>
<div class="lb-trans"><p>山东大学电力技术作为电气行业中的灵活参与者，在过去一年中展现出 19.4% 的显著盈利增长，超过行业平均水平的-1.2%。该公司无债务交易，且交易价格低于其估计的公允价值 21.1%，表明市场可能低估。最近完成了一笔价值 5.37 亿人民币的首次公开募股，股票定价为 14.66 人民币，尽管其流动性较低且缺乏近期财务数据更新，但似乎有进一步扩展的潜力。该公司报告了高质量的盈利，在当前挑战中呈现出引人注目的机会。</p>
</div><ul>
<li>Navigate through the intricacies of Shandong University Electric Power Technology with our comprehensive health report here.</li>
<li>Gain insights into Shandong University Electric Power Technology's historical performance by reviewing our past performance report.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过我们的综合健康报告，深入了解山东大学电力技术的复杂性。</li>
<li>通过查看我们的历史业绩报告，获取山东大学电力技术的历史表现洞察。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/6f87b60c-2f2a-4e58-aece-5e623eddf3dc/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/6f87b60c-2f2a-4e58-aece-5e623eddf3dc/chart/debt-equity-history-analysis"/></p>
<p>SZSE:301609 Debt to Equity as at Jul 2025</p>
<div class="lb-trans"><p>SZSE:301609 截至 2025 年 7 月的债务与股本比率</p>
</div><h2>Make It Happen</h2>
<div class="lb-trans"><h2>让它发生</h2>
</div><ul>
<li>Take a closer look at our Global Undiscovered Gems With Strong Fundamentals list of 3163 companies by clicking here.</li>
<li>Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.</li>
<li>Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里，仔细查看我们全球未被发现的强基本面公司名单，共 3163 家公司。</li>
<li>投资了这些股票吗？通过 Simply Wall St 简化您的投资组合管理，并通过我们的警报及时了解您股票的任何重要更新。</li>
<li>使用 Simply Wall St 应用程序提升您的投资能力，享受覆盖每个大洲的基本市场情报的免费访问。</li>
</ul>
</div><h2>Looking For Alternative Opportunities?</h2>
<div class="lb-trans"><h2>寻找替代机会？</h2>
</div><ul>
<li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li>
<li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li>
<li>Find companies with promising cash flow potential yet trading below their fair value.</li>
</ul>
<div class="lb-trans"><ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>用显示强劲增长潜力的公司充实您的投资组合，这些公司得到了分析师和管理层的乐观展望支持。</li>
<li>寻找现金流潜力良好但交易价格低于其公允价值的公司。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div>

全球市场中有 3 个未被发现的宝石可以提升您的投资组合